Considering that endogenous expression and in vivo administration of FGF21 following stroke could impact multiple cell types (such as microglia), meaning that any observed alterations in astrocytes may be an indirect result of changes in other cell types, exogenous rhFGF21 was directly added to stimulate primary astrocytes in in vitro experiments. This evidence concerns the gene FGF21 and stroke disorder.